Prosonix To Present Results Of Phase 2 Clinical Study Of PSX1002 In Chronic Obstructive Pulmonary Disease (COPD) At The American Thoracic Society Meeting

OXFORD, England, May 15, 2014 /PRNewswire via COMTEX/ -- OXFORD, England, May 15, 2014 /PRNewswire/ --

First full presentation of data from randomised clinical study of glycopyrronium bromide made using Prosonix ' novel particle-engineering technology

Help employers find you! Check out all the jobs and post your resume.